Viscosupplementation
Brand
Availability
Cingal 4ml is an advanced injectable treatment designed to provide both immediate and long-term relief for joint discomfort, particularly in the knee. It combines high-purity hyaluronic acid with a sustained-release corticosteroid, offering a dual-action approach: instant pain relief and long-lasting joint lubrication. This combination helps reduce inflammation, improve mobility, and support joint function, making it suitable for patients experiencing osteoarthritis-related discomfort.
£75.00 Excl. Tax
Monovisc® is an advanced viscosupplement specifically designed to alleviate knee joint pain associated with osteoarthritis (OA) through a single injection. This treatment is formulated with highly purified, partially cross-linked sodium hyaluronate (NaHA) suspended in a phosphate-buffered saline solution. Known for its biocompatibility and resorbability, Monovisc® effectively integrates into the body, providing relief and improving joint function.
£86.31 Excl. Tax
Orthovisc is a highly refined, injectable viscosupplement composed of high molecular weight hyaluronic acid (HA) designed to alleviate joint pain associated with osteoarthritis. It consists of highly purified sodium hyaluronate (NaHA) in a physiologic saline solution, ensuring its biocompatibility and resorbability.
£26.00 Excl. Tax
Synvisc (hylan G-F 20) is an injection used as a viscosupplement to enhance the fluid in your knee, aiming to lubricate and cushion the joint. This sterile, high molecular weight fluid consists of Hylan A fluid, Hylan B gel, and saline, and is designed to manage osteoarthritis pain in joints such as the knee, hip, ankle, or shoulder. By restoring the joint’s elasticity and viscosity, Synvisc facilitates greater range of motion. It serves as a temporary replacement and supplement for synovial fluid in osteoarthritis patients who have not found relief from more conservative, non-drug treatments.
£149.95 Excl. Tax
Synvisc One is a single-dose injection specifically designed to alleviate knee pain in patients with osteoarthritis. By restoring the joint’s elasticity and viscosity, this treatment enables more extensive joint movement. Additionally, Synvisc supplements the fluid in the knee, providing lubrication and cushioning for the joint. It is intended for patients with knee osteoarthritis who have not found adequate relief from nonpharmacologic therapies or simple analgesics like acetaminophen.
£149.95 Excl. Tax
